Allogene Therapeutics ALLO Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's interest income?
- Allogene Therapeutics (ALLO) reported interest income of $3.57M in Q1 2026.
- How has Allogene Therapeutics's interest income changed year-over-year?
- Allogene Therapeutics's interest income decreased by 35.2% year-over-year, from $5.52M to $3.57M.
- What is the long-term trend for Allogene Therapeutics's interest income?
- Over 4 years (2021 to 2025), Allogene Therapeutics's interest income has grown at a 83.2% compound annual growth rate (CAGR), from $1.71M to $19.29M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.